⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 28, 2026

Spirobene 100 mg - Tabletten 100 mg (Tablette)

📷 Wikipedia: Spironolactone · Source
Spirobene 100 mg - Tabletten 100 mg (Tablette)
📷 Wikipedia: Spironolactone · Source
Spirobene 100 mg tablets are subject to a parallel export ban. Production delays have affected availability. The affected pack size is the 50-tablet box, which is unavailable since 24 August 2026. The 20-tablet box remains available.
⚠️
Shortage ongoing
SPIRONOLACTON is currently in short supply in AT.
📈 Timeline
13 days active so far
August 29, 2026 September 10, 2026

What is this? Spirobene 100 mg is a tablet that contains spironolactone. It is used for certain health problems.

What's happening? The 50-tablet pack is not available. The 20-tablet pack is still in stock.

Does this affect me? If you take the 50-tablet pack, you may need to check your supply.

What should I do? Ask your pharmacist or doctor about other options or supplies.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
SPIRONOLACTON
Agency-published detail

🚫 Parallel export ban active · ATC: C03DA01 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 50 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-24] · 20 Stück Schachtel, Blisterpackung [verfügbar]

First published
August 28, 2026
Last refreshed by us
14 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 months ago

Spirobene 50 mg - Tabletten 50 mg (Tablette)

Spirobene 50 mg - Tablets 50 mg (tablet) Parallel export ban in effect. Affected packs: 50-tablet box and blister pack unavailable since 29 June 2026; 20-tablet box and blister pack available.
High AT 4 months ago

Furo-Spirobene forte - Filmtabletten (Filmtablette)

Furo-Spirobene forte film-coated tablets are temporarily unavailable due to a manufacturing delay. Parallel export is prohibited.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Spirobene 100 mg - Tabletten 100 mg (Tablette). Spirobene 100 mg tablets are subject to a parallel export ban. Production delays have affected availability. The affected pack size is the 50-tablet box, which is unavailable since 24 August 2026. The 20-tablet box remains available.
▸ When was this alert issued?
This alert was issued on August 28, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.